Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainZnF_C3H1

RBM22 ZFP36L1 MBNL2 MBNL3

4.67e-0748254SM00356
Domainzf-CCCH

RBM22 ZFP36L1 MBNL2 MBNL3

5.08e-0749254PF00642
DomainZnf_CCCH

RBM22 ZFP36L1 MBNL2 MBNL3

1.01e-0658254IPR000571
DomainZF_C3H1

RBM22 ZFP36L1 MBNL2 MBNL3

1.01e-0658254PS50103
Domain-

ZFP36L1 MBNL2 MBNL3

2.03e-05402534.10.1000.10
DomainRRM_1

RBM22 RBM25 SETD1B U2SURP

1.57e-04208254PF00076
DomainRRM

RBM22 RBM25 SETD1B U2SURP

1.85e-04217254SM00360
DomainRRM_dom

RBM22 RBM25 SETD1B U2SURP

2.20e-04227254IPR000504
DomainRRM

RBM22 RBM25 SETD1B U2SURP

2.31e-04230254PS50102
Domain-

RBM22 RBM25 SETD1B U2SURP

2.90e-042442543.30.70.330
DomainNucleotide-bd_a/b_plait

RBM22 RBM25 SETD1B U2SURP

3.58e-04258254IPR012677
PathwayBIOCARTA_WNT_PATHWAY

FZD1 TLE1

2.64e-0423152MM1527
PathwayBIOCARTA_WNT_PATHWAY

FZD1 TLE1

2.88e-0424152M16517
PathwayKEGG_SPLICEOSOME

RBM22 RBM25 U2SURP

3.00e-04127153M2044
PathwayREACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT

FZD1 USP8 TLE1

5.69e-04158153MM14791
PathwayPID_PS1_PATHWAY

FZD1 TLE1

1.06e-0346152M70
PathwayREACTOME_MRNA_SPLICING

RBM22 RBM25 U2SURP

1.14e-03201153MM15411
PathwayREACTOME_MRNA_SPLICING

RBM22 RBM25 U2SURP

1.34e-03212153M14033
PathwayREACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT

FZD1 USP8 TLE1

1.75e-03233153M27099
PathwayREACTOME_SIGNALING_BY_WNT

FZD1 USP8 TLE1

1.88e-03239153MM14756
PathwayREACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA

RBM22 RBM25 U2SURP

2.87e-03277153MM15414
PathwayREACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA

RBM22 RBM25 U2SURP

3.05e-03283153M13087
PathwayREACTOME_METABOLISM_OF_RNA

RBM22 RBM25 ZFP36L1 U2SURP

3.27e-03612154MM15547
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

RBM22 RBM25 MBNL2 DROSHA PRRC2C MBNL3 U2SURP

1.18e-0680725722681889
Pubmed

Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease.

MBNL2 MBNL3

1.49e-06325225263597
Pubmed

Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle.

MBNL2 MBNL3

1.49e-06325219095965
Pubmed

Loss of MBNL1 induces RNA misprocessing in the thymus and peripheral blood.

MBNL2 MBNL3

1.49e-06325232332745
Pubmed

Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells.

MBNL2 MBNL3

1.49e-06325211929853
Pubmed

Muscleblind proteins regulate alternative splicing.

MBNL2 MBNL3

1.49e-06325215257297
Pubmed

Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy.

MBNL2 MBNL3

1.49e-06325228698297
Pubmed

Developmental expression of mouse muscleblind genes Mbnl1, Mbnl2 and Mbnl3.

MBNL2 MBNL3

2.97e-06425212915312
Pubmed

Muscleblind-Like 1 and Muscleblind-Like 3 Depletion Synergistically Enhances Myotonia by Altering Clc-1 RNA Translation.

MBNL2 MBNL3

2.97e-06425226501102
Pubmed

MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1.

MBNL2 MBNL3

7.43e-06625219720736
Pubmed

Nolz1 promotes striatal neurogenesis through the regulation of retinoic acid signaling.

GSX2 TLE1

1.39e-05825220735826
Pubmed

Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

ZSWIM8 SETD1B LMTK3 PRRC2C SCN9A

1.97e-0547525531040226
Pubmed

The X-linked splicing regulator MBNL3 has been co-opted to restrict placental growth in eutherians.

MBNL2 MBNL3

2.22e-051025235476669
Pubmed

Spatial distribution of the full-length members of the Grg family during embryonic neurogenesis reveals a "Grg-mediated repression map" in the mouse telencephalon.

GSX2 TLE1

2.22e-051025230571765
Pubmed

Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1.

MBNL2 MBNL3

3.26e-051225237143315
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

USP8 RBM22 PRRC2C STARD9 U2SURP CEP83 SCN9A

5.17e-05144225735575683
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

ZSWIM8 RBM22 SETD1B DROSHA PRRC2C

5.45e-0558825538580884
Pubmed

A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.

RBM22 RBM25 SETD1B U2SURP

1.04e-0434725416033648
Pubmed

KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4.

RBM22 RBM25 U2SURP

1.11e-0413025335545047
Pubmed

Conditionals by inversion provide a universal method for the generation of conditional alleles.

DROSHA SCN9A

1.72e-042725223918385
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

USP8 SETD1B PRRC2C STARD9

1.92e-0440725412693553
Pubmed

Genome-wide association scan of dental caries in the permanent dentition.

FZD1 SCN9A

2.58e-043325223259602
Pubmed

Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.

AUTS2 RBM22 PRRC2C TLE1

2.99e-0445725432344865
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

MIIP USP8 ZFP36L1 PRRC2C STARD9

3.23e-0486125536931259
Pubmed

Gene expression analysis of the embryonic subplate.

FZD1 ZFP36L1 TLE1

3.70e-0419625321862448
Pubmed

Dynamic protein-protein interaction wiring of the human spliceosome.

RBM22 RBM25 U2SURP

3.76e-0419725322365833
Pubmed

Phox2a Defines a Developmental Origin of the Anterolateral System in Mice and Humans.

SHOX2 SCN9A

3.80e-044025233238113
Pubmed

Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.

LMTK3 STARD9 SCN9A

6.12e-0423325337704626
GeneFamilyZinc fingers CCCH-type

RBM22 MBNL2 MBNL3

5.32e-063518373
GeneFamilyRNA binding motif containing

RBM22 RBM25 SETD1B U2SURP

5.03e-05213184725
ToppCelldroplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RBM25 ZFP36L1 MBNL2 PRRC2C

3.49e-06188254d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

AUTS2 USP8 MBNL2 TLE1

3.56e-06189254b13f315f617840eb5143a4e8a33a657c20365c21
ToppCell(3)_Chondrocytes-(30)_Chondro|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis

FZD1 AUTS2 SHOX2 ZFP36L1

4.03e-06195254f5597d3ed37770c6fa2b339f98a80ac7ecd4f9ff
ToppCellBrain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type.

RBM25 ZFP36L1 PRRC2C SCN9A

4.46e-062002547c261e39ac30b318511373ab7302aa53b8b81b9c
ToppCellSmart-seq2-thymus_(Smart-seq2)-lymphocytic-T_lymphocytic|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

AUTS2 STARD9 U2SURP

5.29e-051312531be75b37d87942941f6f46009373d79647107ca9
ToppCellSmart-seq2-thymus_(Smart-seq2)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

AUTS2 STARD9 U2SURP

5.29e-05131253c84d4c764482353ba226f8707f736260da9dff13
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

GSX2 MBNL3 SCN9A

8.39e-051532539c6fce56300ba5053efda59a438d63a808c497c0
ToppCell5'-Adult-Appendix-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ZFP36L1 TLE1 CEP83

1.01e-0416325300e791358a7eb6c3e95f87afe22153845012e4a1
ToppCell3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue

FZD1 ZFP36L1 SCN9A

1.13e-04169253241644823e6f949aaf4c671d4579721d7ef6b0e5
ToppCellSevere-B_naive-12|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

GSX2 ZFP36L1 TLE1

1.36e-04180253bc20e581d37cba72b71ef62df60475a0ccee9994
ToppCellSmart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

RBM25 ZFP36L1 PRRC2C

1.50e-0418625323b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCelldroplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RBM25 MBNL2 PRRC2C

1.52e-04187253663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCellfacs-Pancreas-Endocrine-3m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AUTS2 TMEM59L SCN9A

1.57e-04189253fcc3713e8200d51074f709f3360fb36efb0a639f
ToppCellILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

AUTS2 CRYBG1 RBM25

1.57e-041892532c8a2fb76ea002bac554bc1c761ce960b5e116e1
ToppCellSevere-MAIT|Severe / Disease group and Cell class

AUTS2 ZFP36L1 TLE1

1.59e-041902531c063dc1b62d9f9912aaf8d0297555a6545f5550
ToppCellfacs-Lung-EPCAM-24m-Epithelial-lung_neuroendocrine_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LMTK3 TMEM59L SCN9A

1.62e-041912538e06cc61eaff1796c2ce014074029408ba88d561
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)

CRYBG1 MBNL2 PRRC2C

1.62e-041912531ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCellfacs-Lung-EPCAM-24m-Epithelial-Neuroendocrine|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LMTK3 TMEM59L SCN9A

1.62e-04191253501d4f6ad389d9ac5051d4247b9bd3da96f713f9
ToppCellILEUM-non-inflamed-(6)_ILC3|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

ZFP36L1 TLE1 CEP83

1.62e-041912536eaf72b41084404bee0db04e4605db745a74995f
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZFP36L1 MBNL2 TLE1

1.64e-04192253446c61c0d6ba89c619efe87ee495951299953981
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZFP36L1 MBNL2 TLE1

1.67e-04193253bbea475d2c4c7b29674ff302529f8f83dd666dcb
ToppCell343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

FZD1 ZFP36L1 SCN9A

1.72e-0419525367b05a0cd2ca9924eca81a92cc6330eecb9d963c
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CRYBG1 MBNL2 PRRC2C

1.72e-04195253ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCellILEUM-inflamed-(6)_ILC3|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

ZFP36L1 TLE1 CEP83

1.72e-04195253c6968da7d2b60c2163e1ff0ffa41340e1ec1d2ed
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-2M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type.

AUTS2 SHOX2 TMEM59L

1.77e-0419725386157ba4f9a40a80bab2404684fe5a7b4ee380c5
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ANGPTL6 ZFP36L1 TMEM59L

1.82e-041992538d71e1fc92ee24deedf23fbb1a85a7fba0d8d436
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ANGPTL6 ZFP36L1 TMEM59L

1.82e-0419925349690494270981eec5b5261c59e0545dff90cc21
ToppCellmegakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class

RBM25 PRRC2C U2SURP

1.82e-0419925399a65887d3c8a2cde26693dd74404b101bba9d58
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial-Astrocyte|GW10 / Sample Type, Dataset, Time_group, and Cell type.

ZFP36L1 MBNL2 STARD9

1.85e-0420025398a994692440cb4f505b050276f0c8022c814a21
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial|GW10 / Sample Type, Dataset, Time_group, and Cell type.

ZFP36L1 MBNL2 STARD9

1.85e-04200253ef222dc4a205d670172dae74990bdb952ac92e5b
DrugAscorbic acid [50-81-7]; Down 200; 22.4uM; MCF7; HT_HG-U133A

FZD1 ZFP36L1 MBNL2 TLE1 MBNL3

2.24e-061992555407_DN
DrugNiclosamide [50-65-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A

MIIP AUTS2 ZFP36L1 MBNL2

2.52e-051582544136_UP
Drugcolchicine; Up 200; 1uM; SKMEL5; HG-U133A

SETD1B MBNL2 PRRC2C TLE1

5.18e-05190254630_UP
DrugICI 182,780; Down 200; 1uM; PC3; HT_HG-U133A

MIIP SHOX2 TLE1 U2SURP

5.62e-051942544429_DN
DrugTiapride hydrochloride [51012-33-0]; Down 200; 11uM; MCF7; HT_HG-U133A

MIIP ZFP36L1 MBNL2 MBNL3

5.73e-051952544686_DN
DrugNaringin hydrate [11032-30-7]; Down 200; 6.6uM; MCF7; HT_HG-U133A

MIIP SHOX2 MBNL2 MBNL3

5.73e-051952543286_DN
DrugAmitryptiline hydrochloride [549-18-8]; Up 200; 12.8uM; HL60; HT_HG-U133A

MIIP RBM25 MBNL2 TLE1

5.85e-051962541865_UP
Drugestradiol, USP; Down 200; 0.1uM; PC3; HT_HG-U133A

USP8 MBNL2 CEP83 SCN9A

5.96e-051972541208_DN
Drugfludrocortisone acetate; Up 200; 1uM; MCF7; HG-U133A

FZD1 ZFP36L1 MBNL2 PRRC2C

5.96e-05197254282_UP
DrugDihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; PC3; HT_HG-U133A

MIIP FZD1 ZFP36L1 U2SURP

5.96e-051972542074_UP
DrugPyrithyldione [77-04-3]; Up 200; 24uM; MCF7; HT_HG-U133A

SHOX2 ZSWIM8 SETD1B MBNL3

5.96e-051972546801_UP
DrugFlorfenicol [73231-34-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A

MIIP FZD1 ZSWIM8 RBM25

5.96e-051972545300_DN
DrugYohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A

FZD1 SHOX2 ZFP36L1 MBNL3

6.08e-051982546777_UP
DrugRibostamycin sulfate salt [53797-35-6]; Up 200; 7.2uM; MCF7; HT_HG-U133A

RBM25 SETD1B ZFP36L1 MBNL3

6.08e-051982546765_UP
DrugIsoniazid [54-85-3]; Up 200; 29.2uM; MCF7; HT_HG-U133A

FZD1 MBNL2 MBNL3 U2SURP

6.08e-051982547197_UP
DrugNilutamide [63612-50-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A

MIIP SHOX2 ZFP36L1 MBNL2

6.08e-051982546481_DN
DrugArticaine hydrochloride [23964-57-0]; Up 200; 12.4uM; PC3; HT_HG-U133A

MIIP FZD1 MBNL2 TLE1

6.20e-051992547272_UP
DrugTheophylline monohydrate [5967-84-0]; Down 200; 20.2uM; HL60; HT_HG-U133A

FZD1 SHOX2 MBNL2 MBNL3

6.20e-051992542986_DN
DrugDelcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A

MIIP FZD1 SHOX2 ZFP36L1

6.20e-051992546033_DN
DrugOxolinic acid [14698-29-4]; Up 200; 15.4uM; PC3; HT_HG-U133A

FZD1 SHOX2 ZFP36L1 TMEM59L

6.20e-051992545094_UP
DrugFluorometholone [426-13-1]; Down 200; 10.6uM; MCF7; HT_HG-U133A

FZD1 AUTS2 SHOX2 ZFP36L1

6.32e-052002546071_DN
Drugcopper(II) chloride

ANGPTL6 DROSHA

2.17e-0420252CID000169664
DrugDronabinol

SHOX2 ANGPTL6 RBM25 ZFP36L1 PRRC2C U2SURP

3.59e-04905256ctd:D013759
Drugciguatoxin

TLE1 SCN9A

6.74e-0435252CID005311333
Drugpyrvinium pamoate; Up 200; 1.25uM; MCF7; HT_HG-U133A_EA

FZD1 ZFP36L1 MBNL2

8.34e-04170253978_UP
DrugFonofos

MIIP CRYBG1 GSX2 TMEM59L SCN9A

9.43e-04714255ctd:D004397
Drugterbufos

MIIP CRYBG1 GSX2 TMEM59L SCN9A

1.00e-03724255ctd:C012568
DrugPerphenazine [58-39-9]; Up 200; 10uM; MCF7; HT_HG-U133A

AUTS2 ZSWIM8 MBNL2

1.05e-031842531540_UP
Drugtrifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A

FZD1 ZFP36L1 MBNL2

1.08e-031862532684_UP
DrugPromazine hydrochloride [53-60-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A

FZD1 MBNL2 TLE1

1.15e-031902533833_DN
DrugPhenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A

ZFP36L1 MBNL2 PRRC2C

1.17e-031912534283_DN
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA

ZFP36L1 TLE1 U2SURP

1.17e-031912531063_DN
DrugDigitoxigenin [143-62-4]; Down 200; 10.6uM; PC3; HT_HG-U133A

MIIP FZD1 U2SURP

1.17e-031912534217_DN
DrugCarbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A

ZSWIM8 MBNL2 TLE1

1.18e-031922534110_DN
DrugPronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A

ZFP36L1 PRRC2C TLE1

1.18e-031922534104_DN
DrugAntimycin A [1397-94-0]; Up 200; 7.2uM; MCF7; HT_HG-U133A

ZSWIM8 ZFP36L1 TMEM59L

1.18e-031922532261_UP
DrugPipenzolate bromide [125-51-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A

SHOX2 TLE1 MBNL3

1.18e-031922533460_UP
Drugestradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A

SETD1B MBNL2 MBNL3

1.18e-031922535238_UP
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A

MIIP ZSWIM8 ZFP36L1

1.18e-031922535222_DN
DrugPramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A

MIIP ZFP36L1 MBNL3

1.18e-031922536054_DN
DrugHeptaminol hydrochloride [543-15-7]; Up 200; 22uM; MCF7; HT_HG-U133A

MIIP ZFP36L1 MBNL2

1.20e-031932531703_UP
DrugChlorpromazine hydrochloride [69-09-0]; Up 200; 11.2uM; HL60; HT_HG-U133A

MIIP MBNL2 TLE1

1.20e-031932531864_UP
DrugTrifluridine [70-00-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A

FZD1 ZSWIM8 MBNL2

1.20e-031932537176_UP
DrugGabapentin [60142-96-3]; Up 200; 23.4uM; MCF7; HT_HG-U133A

MIIP MBNL2 MBNL3

1.20e-031932537229_UP
DrugImipramine hydrochloride [113-52-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A

SHOX2 ZFP36L1 TLE1

1.20e-031932535440_DN
DrugEburnamonine (-) [4880-88-0]; Down 200; 13.6uM; MCF7; HT_HG-U133A

MIIP FZD1 TLE1

1.20e-031932536802_DN
DrugTerazosin hydrochloride [63590-64-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A

ZSWIM8 MBNL2 MBNL3

1.20e-031932537187_UP
Drugradicicol, diheterospora chlamydosporia; Down 200; 0.1uM; PC3; HT_HG-U133A

MIIP SHOX2 TLE1

1.20e-031932534443_DN
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A

ZSWIM8 ZFP36L1 MBNL3

1.20e-031932535215_DN
DrugChlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; PC3; HG-U133A

USP8 RBM25 ZFP36L1

1.20e-031932531958_DN
DrugLY 294002; Down 200; 10uM; PC3; HT_HG-U133A

MIIP RBM25 U2SURP

1.20e-031932531236_DN
DrugButoconazole nitrate [32872-77-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A

ZSWIM8 MBNL2 TMEM59L

1.22e-031942533288_UP
DrugLY 294002; Up 200; 10uM; HL60; HT_HG-U133A

SHOX2 MBNL2 TMEM59L

1.22e-031942536195_UP
DrugBeta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A

CRYBG1 U2SURP CEP83

1.22e-031942533807_DN
DrugFlutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A

RBM25 ZFP36L1 PRRC2C

1.22e-031942534361_DN
DrugUrapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; PC3; HT_HG-U133A

ZSWIM8 MBNL2 TLE1

1.22e-031942536696_UP
DrugFlurandrenolide [1524-88-5]; Up 200; 9.2uM; PC3; HT_HG-U133A

FZD1 SHOX2 SCN9A

1.22e-031942533679_UP
DrugPrenylamine lactate [69-43-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A

SHOX2 MBNL3 U2SURP

1.22e-031942532886_DN
DrugMedrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A

RBM25 MBNL2 MBNL3

1.22e-031942534727_DN
DrugScopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; PC3; HT_HG-U133A

MIIP FZD1 U2SURP

1.22e-031942534219_DN
DrugUngerine nitrate; Down 200; 10.2uM; MCF7; HT_HG-U133A

AUTS2 ZFP36L1 MBNL2

1.22e-031942536076_DN
DrugMetaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; PC3; HT_HG-U133A

ZFP36L1 TLE1 SCN9A

1.22e-031942534248_DN
DrugAcetohexamide [968-81-0]; Up 200; 12.4uM; HL60; HT_HG-U133A

MIIP SHOX2 TLE1

1.24e-031952531870_UP
DrugKarakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A

MIIP AUTS2 ZFP36L1

1.24e-031952536059_DN
DrugHeliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A

MIIP FZD1 ZFP36L1

1.24e-031952536035_DN
DrugBenzathine benzylpenicillin [5928-84-7]; Up 200; 4.2uM; MCF7; HT_HG-U133A

AUTS2 ZFP36L1 TLE1

1.24e-031952537359_UP
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A

ZSWIM8 ZFP36L1 TLE1

1.24e-031952536926_DN
Drugradicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A

ZSWIM8 ZFP36L1 U2SURP

1.24e-031952536938_DN
DrugPiromidic acid [19562-30-2]; Up 200; 13.8uM; MCF7; HT_HG-U133A

FZD1 AUTS2 MBNL2

1.24e-031952533335_UP
DrugLisuride (S)(-) [18016-80-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A

MIIP ZFP36L1 MBNL2

1.24e-031952535028_UP
Drugtrifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A

MIIP FZD1 U2SURP

1.24e-031952531649_DN
DrugPentoxifylline [6493-05-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A

SHOX2 ZFP36L1 MBNL2

1.24e-031952532290_UP
DrugHecogenin [467-55-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A

MIIP SETD1B MBNL3

1.24e-031952537175_UP
DrugAmitryptiline hydrochloride [549-18-8]; Up 200; 12.8uM; MCF7; HT_HG-U133A

AUTS2 MBNL2 TLE1

1.24e-031952531701_UP
DrugPimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A

FZD1 ZSWIM8 U2SURP

1.24e-031952537426_DN
DrugDipyridamole [58-32-2]; Down 200; 8uM; PC3; HG-U133A

USP8 RBM25 ZFP36L1

1.24e-031952531934_DN
DrugBambuterol hydrochloride [81732-46-9]; Up 200; 10uM; MCF7; HT_HG-U133A

SHOX2 ZFP36L1 TMEM59L

1.24e-031952533199_UP
DrugBaclofen (R,S) [1134-47-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A

FZD1 MBNL2 MBNL3

1.26e-031962531536_UP
Drug3-nitropropionic acid; Down 200; 10uM; MCF7; HT_HG-U133A

MIIP MBNL2 MBNL3

1.26e-031962536367_DN
DrugSulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A

MIIP MBNL2 U2SURP

1.26e-031962537200_UP
DrugMetampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; HL60; HG-U133A

MIIP RBM25 TLE1

1.26e-031962531440_UP
DrugPhensuximide [86-34-0]; Up 200; 21.2uM; PC3; HT_HG-U133A

SHOX2 SETD1B ZFP36L1

1.26e-031962535097_UP
DrugPalmatine chloride [3486-67-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A

MIIP ZFP36L1 TLE1

1.26e-031962532795_DN
DrugPempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A

FZD1 ZFP36L1 MBNL3

1.26e-031962533832_DN
DrugNiflumic acid [4394-00-7]; Down 200; 14.2uM; PC3; HT_HG-U133A

FZD1 ZFP36L1 MBNL2

1.26e-031962535071_DN
DrugPicotamide monohydrate [80530-63-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A

MIIP ZSWIM8 ZFP36L1

1.26e-031962532233_UP
DrugClofazimine [2030-63-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A

MIIP SHOX2 ZFP36L1

1.26e-031962535277_UP
DrugPregnenolone [145-13-1]; Down 200; 12.6uM; PC3; HT_HG-U133A

MIIP FZD1 U2SURP

1.26e-031962534218_DN
DrugEdrophonium chloride [116-38-1]; Down 200; 19.8uM; HL60; HG-U133A

RBM25 TLE1 U2SURP

1.26e-031962532019_DN
DrugEthamsylate [2624-44-4]; Up 200; 15.2uM; MCF7; HT_HG-U133A

ZFP36L1 MBNL2 TLE1

1.26e-031962537335_UP
DrugDobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A

MIIP FZD1 ZFP36L1

1.26e-031962535386_DN
DrugMethoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; MCF7; HT_HG-U133A

MIIP MBNL2 MBNL3

1.26e-031962533302_DN
DrugEtofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A

SHOX2 PRRC2C TLE1

1.26e-031962534108_DN
DrugCotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A

MIIP SETD1B MBNL2

1.26e-031962531511_DN
DrugHesperetin [520-33-2]; Up 200; 13.2uM; HL60; HG-U133A

RBM25 TLE1 MBNL3

1.26e-031962532031_UP
Diseasemyotonic disease (implicated_via_orthology)

MBNL2 MBNL3

1.74e-063232DOID:450 (implicated_via_orthology)
Diseasemyotonic dystrophy type 2 (implicated_via_orthology)

MBNL2 MBNL3

5.80e-065232DOID:0050759 (implicated_via_orthology)
Diseasemyotonic dystrophy type 1 (implicated_via_orthology)

MBNL2 MBNL3

8.70e-066232DOID:11722 (implicated_via_orthology)
Diseasearm span

AUTS2 MBNL2

6.06e-0515232EFO_0005108
Diseaseurinary albumin to creatinine ratio

AUTS2 ZFP36L1 PRRC2C

3.56e-04179233EFO_0007778
DiseaseModerate albuminuria

ZFP36L1 PRRC2C

1.77e-0380232HP_0012594
Diseasealbuminuria

ZFP36L1 PRRC2C

2.43e-0394232EFO_0004285
DiseaseEpilepsy

AUTS2 SCN9A

3.25e-03109232C0014544
Diseaseobsolete_red blood cell distribution width

CRYBG1 SETD1B ZFP36L1 PRRC2C U2SURP

3.33e-031347235EFO_0005192
Diseasecognitive function measurement

AUTS2 CRYBG1 RBM25 MBNL2 PRRC2C

4.35e-031434235EFO_0008354
Diseasevisceral adipose tissue measurement

AUTS2 CRYBG1 TLE1

5.98e-03481233EFO_0004765
Diseasemean arterial pressure

AUTS2 USP8 ZFP36L1

6.62e-03499233EFO_0006340
Diseaseblood phosphate measurement

USP8 TMEM59L

8.06e-03174232EFO_0010972
Diseasecardiac troponin I measurement

CRYBG1 MBNL2

8.24e-03176232EFO_0010071
Diseasedental caries

FZD1 SCN9A

9.26e-03187232EFO_0003819
Diseasealcohol use disorder (implicated_via_orthology)

AUTS2 ANGPTL6

1.00e-02195232DOID:1574 (implicated_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
MMEPDWPLYPPPSHA

TMEM59L

311

Q9UK28
SSAMVPSMELPFPPH

CEP83

651

Q9Y592
PHMFHPMGPPPPFMR

RBM22

381

Q9NW64
MSFPPHLNRPPMGIP

RBM25

1

P49756
PMPAPQPSHSDMTTP

LMTK3

111

Q96Q04
FFIPLGMPPPLVMSV

GSX2

31

Q9BZM3
PPTAIMPTPAPPMFD

AUTS2

551

Q8WXX7
PPHPPMSPDFTVFMI

FZD1

591

Q9UP38
EPMASPMPAGHPAVP

ANGPTL6

236

Q8NI99
MQFMFPGTPLHPVPT

MBNL2

101

Q5VZF2
SFPMTPSIPANPPMA

MBNL3

116

Q9NUK0
RMPNSPAPHFAMPPI

CRYBG1

721

Q9Y4K1
QMRHPFPVPPCFPPM

DROSHA

106

Q9NRR4
SPFHPASPMQMLPPT

MIIP

356

Q5JXC2
MTYPPLHGPMRFPPS

PRRC2C

256

Q9Y520
MAMLPPPGPQSFVHF

SCN9A

1

Q15858
HAPYMMFPAPPFGLP

SHOX2

271

O60902
PPFPPGLFPVMQVDM

SETD1B

746

Q9UPS6
PYPMPSTLSHMPTPD

STARD9

3406

Q9P2P6
VPIPPHPIYIPPSMM

U2SURP

356

O15042
PMSESPHMFDSPPSP

ZFP36L1

281

Q07352
SPMVGFDPPPHMRVP

TLE1

416

Q04724
PVPFHMPSPMGLPYS

TEX13C

231

A0A0J9YWL9
PMPHMPRPAVFPVPS

ZSWIM8

1531

A7E2V4
VHMYPPEMAPSSAPP

USP8

676

P40818